![Dorman Followwill](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dorman Followwill
Director/Board Member at
SCILEX HOLDING COMPANY
Net worth: 507 $ as of 29/06/2026
Profile
Dorman Followwill is currently an Independent Director at Semnur Pharmaceuticals, Inc. since 2025, an Independent Director at Scilex Holding Co. since 2022, and a Senior Partner-Transformational Health at Frost & Sullivan, Inc. since 2016.
Former positions include Independent Director at Scilex, Inc. in 2022 and Independent Director at Sorrento Therapeutics, Inc. from 2017 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1985.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/04/2026 | 65 ( 0% ) | 507 $ | 29/06/2026 |
Dorman Followwill active positions
| Companies | Position | Start |
|---|---|---|
| SCILEX HOLDING COMPANY | Director/Board Member | 09/11/2022 |
Frost & Sullivan, Inc.
 Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Corporate Officer/Principal | 31/12/2015 |
Former positions of Dorman Followwill
| Companies | Position | End |
|---|---|---|
Scilex, Inc.
 Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Director/Board Member | 31/10/2022 |
| SORRENTO THERAPEUTICS, INC. | Director/Board Member | - |
Training of Dorman Followwill
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frost & Sullivan, Inc.
Frost & Sullivan, Inc. Investment ManagersFinance Provides investment research | Finance |
Sorrento Therapeutics, Inc.
 Sorrento Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain | Health Technology |
Scilex, Inc.
Scilex, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pain management pharmaceutical products | Health Technology |
Scilex Holding Co.
 Scilex Holding Co. Pharmaceuticals: OtherHealth Technology Manufactures and wholesales non-opioid pain management products | Health Technology |
- Stock Market
- Insiders
- Dorman Followwill
